These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11104345)

  • 1. Patterns of neuropsychological deficits in children with medulloblastoma according to craniospatial irradiation doses.
    Kieffer-Renaux V; Bulteau C; Grill J; Kalifa C; Viguier D; Jambaque I
    Dev Med Child Neurol; 2000 Nov; 42(11):741-5. PubMed ID: 11104345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.
    Ris MD; Packer R; Goldwein J; Jones-Wallace D; Boyett JM
    J Clin Oncol; 2001 Aug; 19(15):3470-6. PubMed ID: 11481352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological outcome of children after radiotherapy for intracranial tumours.
    García-Peréz A; Narbona-García J; Sierrasesúmaga L; Aguirre-Ventalló M; Calvo-Manuel F
    Dev Med Child Neurol; 1993 Feb; 35(2):139-48. PubMed ID: 8444327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes.
    Grill J; Renaux VK; Bulteau C; Viguier D; Levy-Piebois C; Sainte-Rose C; Dellatolas G; Raquin MA; Jambaqué I; Kalifa C
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):137-45. PubMed ID: 10477017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma.
    Palmer SL; Gajjar A; Reddick WE; Glass JO; Kun LE; Wu S; Xiong X; Mulhern RK
    Neuropsychology; 2003 Oct; 17(4):548-55. PubMed ID: 14599268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive deficits in long-term survivors of childhood medulloblastoma and other noncortical tumors: age-dependent effects of whole brain radiation.
    Radcliffe J; Bunin GR; Sutton LN; Goldwein JW; Phillips PC
    Int J Dev Neurosci; 1994 Jun; 12(4):327-34. PubMed ID: 7976487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical risk factors for intellectual impairment in children with posterior fossa tumors: the role of cerebellar damage.
    Grill J; Viguier D; Kieffer V; Bulteau C; Sainte-Rose C; Hartmann O; Kalifa C; Dellatolas G
    J Neurosurg; 2004 Nov; 101(2 Suppl):152-8. PubMed ID: 15835102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.
    Carrie C; Grill J; Figarella-Branger D; Bernier V; Padovani L; Habrand JL; Benhassel M; Mege M; Mahé M; Quetin P; Maire JP; Baron MH; Clavere P; Chapet S; Maingon P; Alapetite C; Claude L; Laprie A; Dussart S
    J Clin Oncol; 2009 Apr; 27(11):1879-83. PubMed ID: 19273707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late effects of radiotherapy on patients with cerebellar medulloblastoma.
    Silverman CL; Palkes H; Talent B; Kovnar E; Clouse JW; Thomas PR
    Cancer; 1984 Sep; 54(5):825-9. PubMed ID: 6744214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
    J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic schedules influence the pattern of intellectual decline after irradiation of posterior fossa tumors.
    Kieffer-Renaux V; Viguier D; Raquin MA; Laurent-Vannier A; Habrand JL; Dellatolas G; Kalifa C; Hartmann O; Grill J
    Pediatr Blood Cancer; 2005 Nov; 45(6):814-9. PubMed ID: 15924360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological Outcome of Children Treated for Standard Risk Medulloblastoma in the PNET4 European Randomized Controlled Trial of Hyperfractionated Versus Standard Radiation Therapy and Maintenance Chemotherapy.
    Câmara-Costa H; Resch A; Kieffer V; Lalande C; Poggi G; Kennedy C; Bull K; Calaminus G; Grill J; Doz F; Rutkowski S; Massimino M; Kortmann RD; Lannering B; Dellatolas G; Chevignard M;
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):978-985. PubMed ID: 26194675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced neurocognitive decline: the risks and benefits of reducing the amount of whole-brain irradiation.
    Packer RJ
    Curr Neurol Neurosci Rep; 2002 Mar; 2(2):131-3. PubMed ID: 11898479
    [No Abstract]   [Full Text] [Related]  

  • 15. Undernutrition and Pubertal Timing in Female Survivors of Medulloblastoma and Other Embryonal Tumors.
    Zhu J; Feldman HA; Chordas C; Wassner AJ; Manley PE; Cohen LE
    J Clin Endocrinol Metab; 2020 Oct; 105(10):e3650-9. PubMed ID: 32706870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.
    Douw L; Klein M; Fagel SS; van den Heuvel J; Taphoorn MJ; Aaronson NK; Postma TJ; Vandertop WP; Mooij JJ; Boerman RH; Beute GN; Sluimer JD; Slotman BJ; Reijneveld JC; Heimans JJ
    Lancet Neurol; 2009 Sep; 8(9):810-8. PubMed ID: 19665931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma.
    Merchant TE; Kiehna EN; Li C; Shukla H; Sengupta S; Xiong X; Gajjar A; Mulhern RK
    Int J Radiat Oncol Biol Phys; 2006 May; 65(1):210-21. PubMed ID: 16472938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive sequelae in children with posterior fossa tumors.
    George AP; Kuehn SM; Vassilyadi M; Richards PM; Parlow SE; Keene DL; Ventureyra EC
    Pediatr Neurol; 2003 Jan; 28(1):42-7. PubMed ID: 12657419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medulloblastoma: time-dose relationship based on a 30-year review.
    del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of craniospinal dose, boost volume, and neurologic complications on intellectual outcome in patients with medulloblastoma.
    Moxon-Emre I; Bouffet E; Taylor MD; Laperriere N; Scantlebury N; Law N; Spiegler BJ; Malkin D; Janzen L; Mabbott D
    J Clin Oncol; 2014 Jun; 32(17):1760-8. PubMed ID: 24516024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.